Combined Effects of Multiple Flavonoids on Breast Cancer Resistance Protein (ABCG2)-mediated Transport

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2004 Aug 5

PMID 15290869

Citations 35

Authors

Shuzhong Zhang

Xinning Yang

Marilyn E Morris

Affiliations

Soon will be listed here.

Abstract

Purpose: The purpose of this study was to determine the dynamic parameter (EC50) of flavonoids apigenin, biochanin A, chrysin, genistein, kaempferol, hesperetin, naringenin, and silymarin for breast cancer resistance protein (BCRP) inhibition when used alone, and to evaluate their potential interactions (additive, synergistic, or antagonistic) with regards to BCRP inhibition when used in multiple-flavonoid combinations.

Methods: The effects of flavonoids on BCRP-mediated transport were examined by evaluating their effects on mitoxantrone accumulation and cytotoxicity in MCF-7 MX100 cells overexpressing BCRP. The EC50 values of these flavonoids for increasing mitoxantrone accumulation were estimated using a Hill equation. The potential interactions among multiple flavonoids with regard to BCRP inhibition were assessed by isobologram and Berenbaum's interaction index methods.

Results: The EC50 values of these flavonoids for increasing mitoxantrone accumulation ranged from 0.39+/-0.13 microM to 33.7+/-2.78 microM. Quantitative analysis of the combined effects of multiple flavonoids on mitoxantrone accumulation indicated that these flavonoids act additively in inhibiting BCRP when given as 2-, 3-, 5-, or 8-flavonoid combinations with equimolar concentrations of all constituents. The results of the mitoxantrone cytotoxicity studies were consistent with these findings.

Conclusions: The additive effects of multiple flavonoids for BCRP inhibition suggests that prediction of BCRP-mediated food (herbal product)-drug interactions should also take into consideration the presence of multiple flavonoids and provides a rationale for using "flavonoid cocktails" as a potential approach for multidrug resistance reversal in cancer treatment.

Citing Articles

Pharmacokinetics of Dasatinib in Rats: a Potential Food-Drug Interaction with Naringenin.

Raish M, Ahmad A, Karim B, Bin Jardan Y, Ahad A, Iqbal M Eur J Drug Metab Pharmacokinet. 2024; 49(2):239-247.

PMID: 38376657 DOI: 10.1007/s13318-024-00881-9.

In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism.

Zhang W, Zhang Y, Wen C, Jiang X, Wang L Planta Med. 2023; 89(13):1195-1203.

PMID: 37236224 PMC: 10575715. DOI: 10.1055/a-2102-0648.

Chemosensitizing effect and mechanism of imperatorin on the anti-tumor activity of doxorubicin in tumor cells and transplantation tumor model.

Liang X, Ji M, Liao Z, Zhao G, Tang X, Dong W Korean J Physiol Pharmacol. 2022; 26(3):145-155.

PMID: 35477542 PMC: 9046893. DOI: 10.4196/kjpp.2022.26.3.145.

Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions.

Koltai T, Fliegel L J Evid Based Integr Med. 2022; 27:2515690X211068826.

PMID: 35018864 PMC: 8814827. DOI: 10.1177/2515690X211068826.

Role of Flavonoids in The Interactions among Obesity, Inflammation, and Autophagy.

Garcia-Barrado M, Iglesias-Osma M, Perez-Garcia E, Carrero S, Blanco E, Carretero-Hernandez M Pharmaceuticals (Basel). 2020; 13(11).

PMID: 33114725 PMC: 7692407. DOI: 10.3390/ph13110342.

References

Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D . New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990; 82(13):1107-12. DOI: 10.1093/jnci/82.13.1107. View

MIDDLETON Jr E, Kandaswami C, Theoharides T . The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52(4):673-751. View

Robey R, Nishiyama K, Lahusen T, Miyake K, Litman T, Senderowicz A . Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells. Clin Cancer Res. 2001; 7(1):145-52. View

Allikmets R, Schriml L, Hutchinson A, Romano-Spica V, Dean M . A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res. 1998; 58(23):5337-9. View

Ross D, Karp J, Chen T, Doyle L . Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood. 2000; 96(1):365-8. View

Sargent J, Williamson C, Maliepaard M, Elgie A, Scheper R, Taylor C . Breast cancer resistance protein expression and resistance to daunorubicin in blast cells from patients with acute myeloid leukaemia. Br J Haematol. 2001; 115(2):257-62. DOI: 10.1046/j.1365-2141.2001.03122.x. View

Maliepaard M, Scheffer G, Faneyte I, van Gastelen M, Pijnenborg A, Schinkel A . Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 2001; 61(8):3458-64. View

Kruijtzer C, Beijnen J, Rosing H, Ten Bokkel Huinink W, Schot M, Jewell R . Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. J Clin Oncol. 2002; 20(13):2943-50. DOI: 10.1200/JCO.2002.12.116. View

Howes J, Sullivan D, Lai N, Nestel P, Pomeroy S, West L . The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis. 2000; 152(1):143-7. DOI: 10.1016/s0021-9150(99)00437-2. View

10.

Davies B, Morris T . Physiological parameters in laboratory animals and humans. Pharm Res. 1993; 10(7):1093-5. DOI: 10.1023/a:1018943613122. View

11.

Kohno H, Tanaka T, Kawabata K, Hirose Y, Sugie S, Tsuda H . Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer. 2002; 101(5):461-8. DOI: 10.1002/ijc.10625. View

12.

Maliepaard M, van Gastelen M, de Jong L, Pluim D, van Waardenburg R, Floot B . Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res. 1999; 59(18):4559-63. View

13.

Greco W, Bravo G, Parsons J . The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 1995; 47(2):331-85. View

14.

Jonker J, Smit J, Brinkhuis R, Maliepaard M, Beijnen J, Schellens J . Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst. 2000; 92(20):1651-6. DOI: 10.1093/jnci/92.20.1651. View

15.

Manach C, Morand C, Gil-Izquierdo A, Bouteloup-Demange C, Remesy C . Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr. 2003; 57(2):235-42. DOI: 10.1038/sj.ejcn.1601547. View

16.

Setchell K, Brown N, Desai P, Zimmer-Nechemias L, Wolfe B, Brashear W . Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001; 131(4 Suppl):1362S-75S. DOI: 10.1093/jn/131.4.1362S. View

17.

Kanzaki A, Toi M, Nakayama K, Bando H, Mutoh M, Uchida T . Expression of multidrug resistance-related transporters in human breast carcinoma. Jpn J Cancer Res. 2001; 92(4):452-8. PMC: 5926724. DOI: 10.1111/j.1349-7006.2001.tb01115.x. View

18.

Piscitelli S, Formentini E, Burstein A, Alfaro R, Jagannatha S, Falloon J . Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers. Pharmacotherapy. 2002; 22(5):551-6. DOI: 10.1592/phco.22.8.551.33205. View

19.

Litman T, Druley T, Stein W, Bates S . From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol Life Sci. 2001; 58(7):931-59. PMC: 11337370. DOI: 10.1007/PL00000912. View

20.

Gessner P . Isobolographic analysis of interactions: an update on applications and utility. Toxicology. 1995; 105(2-3):161-79. DOI: 10.1016/0300-483x(95)03210-7. View